Table 1.
Baseline Patient and Disease Characteristics
Characteristic | N=138 |
---|---|
Median age, years (range) | 61 (21-87) |
Sex (M) | 84 (61%) |
Race | |
White | 122 (88%) |
Asian | 6 (4.3%) |
Black | 2 (1.4%) |
Unknown | 8 (5.8%) |
Primary tumor location | |
Colorectal | 69 (50%) |
Pancreas | 26 (19%) |
Biliary | 18 (13%) |
Esophagogastric | 17 (12%) |
Other | 8 (5.8%) |
Therapy types | |
Cytotoxic therapy only | 97 (70%) |
Targeted therapy only | 23 (17%) |
Targeted + cytotoxic therapy | 18 (13%) |
Metastatic at Diagnosis | 83 (60%) |
Median time from metastatic diagnosis to treatment start, months (range) | 2.1 (0-205) |
Lines of prior metastatic therapy, median (range) | 0 (0-6) |
1st line therapy | 78 (57%) |
2nd line therapy | 31 (22%) |
3rd line therapy or later | 29 (21%) |